2026-09-24T06:22:49Zhttps://ruor.uottawa.ca/server/oai/request

oai:ruor.uottawa.ca:10393/89092024-02-23T09:02:27Zcom_10393_242col_10393_244

Non-steriodal anti-inflammatory drug-mediated regulation of COX-2 and EP3 receptor expression in the M-1 murine cortical collecting duct cell line. Ferguson, Shawn. Hebert, Richard L., Health Sciences, Pharmacology. The cortical collecting duct (CCD) is a major site of intrarenal prostaglandin E2 (PGE2) synthesis. By indirect immunofluorescence using isoform specific antibodies, we have localized COX-1 and -2 immunoreactivity to all cell types of the murine M-1 CCD cell line. By, immunohistochemistry, both COX-1 and COX-2 were localized to the intercalated cells of the collecting duct on paraffin embedded mouse kidney sections. When COX enzyme activity was measured in the M-1 cells, both indomethacin (COX-1 and -2 inhibitor) and the specific COX-2 inhibitor NS-398 effectively blocked PGE2 synthesis. These results demonstrate that COX-2 is a major contributor to the pool of PGE2 synthesized by the CCD. PGE2 exerts predominantly diuretic and natriuretic effects upon the CCD. Our results which document the expression of COX-2 in the CCD provide a mechanism through which the newly developed class of COX-2 specific inhibitors could exert side effects with respect to the regulation of fluid and electrolyte homeostasis. (Abstract shortened by UMI.) 2009-03-23T17:39:55Z 2009-03-23T17:39:55Z 1999 1999 Thesis Source: Masters Abstracts International, Volume: 40-06, page: 1507. 9780612678149 http://hdl.handle.net/10393/8909 http://dx.doi.org/10.20381/ruor-7551 132 p. application/pdf University of Ottawa (Canada)